SEC Form 4 · accession 0001980648-26-000017
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chan Henry Lee
Officer — SVP, General Counsel
Period of report
Jul 8, 2026
Accepted (ET)
Jul 10, 2026 · 4:44 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1 | Jul 8, 2026 | M | 202 | $194.47 | A | 202 | D | |
| American Depositary SharesF1 | Jul 8, 2026 | M | 266 | $213.32 | A | 468 | D | |
| American Depositary SharesF1 | Jul 8, 2026 | M | 196 | $159.03 | A | 664 | D | |
| American Depositary SharesF1 | Jul 8, 2026 | S | 664 | $302.46 | D | 0 | D | |
| Ordinary Shares | holding | — | — | — | 338,884 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F3,F4 | $14.96 | Jul 8, 2026 | M | 2,626 | D | — | Aug 4, 2032 | Ordinary Shares | 2,626 | 17,238 | D |
| Share Option (Right to Buy)F3,F5 | $16.41 | Jul 8, 2026 | M | 3,458 | D | — | Jun 14, 2033 | Ordinary Shares | 3,458 | 79,768 | D |
| Share Option (Right to Buy)F3,F6 | $12.23 | Jul 8, 2026 | M | 2,548 | D | — | Jun 4, 2034 | Ordinary Shares | 2,548 | 105,300 | D |
Explanation of responses
- F1Each American Depositary Share represents 13 Ordinary Shares.
- F2The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.
- F3The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.
- F4These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- F5These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- F6These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
Remarks
Exhibit List - Exhibit 24.1 - Power of Attorney